Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

JNJ 102.40 +0.44 (0.43%)
price chart
'Frozen,' 'Star Wars' fuel Band-Aid comeback for Johnson & Johnson
When Greg Marcotte's daughters scrape a knee, they paste on a Band-Aid that's more than just a way to cover a wound. "I almost feel like they're a fashion accessory," Marcotte, a high school math teacher in Worcester, Mass.
Court revives Oregon suit over Johnson & Johnson's 'phantom recall' of Motrin
PORTLAND - A lawsuit over Johnson & Johnson's buyback of defective Motrin pills has been given new life by the Oregon Court of Appeals.
Oregon lawsuit over Motrin maker's 'phantom recall' revived on ...
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
16, Johnson & Johnson announced that the Food and Drug Administration had approved Darzalex (scientifically known as daratumumab) for the treatment of relapsed multiple myeloma in patients who have tried and progressed on at least three therapies.
How Johnson & Johnson Spent $71 Billion in 12 Months
Business is good at Johnson & Johnson (NYSE:JNJ). Over the last 12 months, it's earned $71 billion in revenue, ranking 40th among S&P 500 companies.
News Review: Huntsman Corporation (HUN), Silver Wheaton Corp USA (SLW ...  Investor Wired
Johnson & Johnson Multiple Myeloma Drug Wins Accelerated OK
A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple myeloma in patients who've failed prior therapies and have few options left.
Why Johnson & Johnson Stock Is a Better Buy Than Pfizer
Johnson & Johnson is well-known for its consumer brands, while Pfizer is more often compared with purer-play drugmakers Merck & Co.
Do Hedge Funds Love Johnson & Johnson (JNJ)?
Johnson & Johnson investors should pay attention to a decrease in activity from the world's largest hedge funds of late.
It Seems Johnson & Johnson Will Go Down. Had Bearish Options Activity
In today's session Johnson & Johnson (JNJ) recorded an unusually high (2,046) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the January, 2016 put, expecting serious JNJ decrease.
Johnson & Johnson (NYSE:JNJ) Ratings Update  The Bulletin
Investors Sell Johnson & Johnson on Strength (JNJ)  Putnam Standard
Johnson & Johnson to Pay $1.75 Million Risperdal Lawsuit Verdict
A Philadelphia jury ordered Johnson & Johnson's subsidiary Janssen Pharmaceuticals to pay $1.75 million to a man who developed female breasts after taking the antipsychotic Risperdal (risperidone) as a child.
Johnson & Johnson Pays a Healthy Dividend and Prescribes Strong Value
Shares of health care giant Johnson & Johnson (JNJ - Get Report) are scheduled to trade ex-dividend Friday, Nov. 20. To qualify for a dividend check, investors must own shares of the company on or before its ex-dividend date.
These 5 Companies Own 491 Million Shares of Johnson & Johnson  Motley Fool
Ex-Dividend Reminder: Brunswick, Callaway Golf and Johnson & Johnson  Forbes